#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13906	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2469	693.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1913	1913	T	936	T,G,A	932,2,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13906	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2469	693.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1647	1647	C	883	C,T	882,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23466	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4142	706.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	2000	2000	A	1049	A,G	1048,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23466	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4142	706.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2634	2634	C	802	C,T,G	800,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23466	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4142	706.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3260	3260	T	801	T,C,G	799,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23466	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4142	706.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2708	2708	A	711	A	711	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	G5V	NONSYN	13	15	GGT	625	627	GTT	129;129;130	G;T,G,C;T	129;127,1,1;130	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	E12K	NONSYN	34	36	GAA	646	648	AAA	140;142;146	A;A;A	140;142;146	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	F31L	NONSYN	91	93	TTT	703	705	TTG	156;157;157	T;T;G	156;157;157	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	736	738	CAA	177;175;172	C;A,C;A	177;174,1;172	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	S75P	NONSYN	223	225	TCC	835	837	CCT	169;172;172	C;C;T	169;172;172	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	V87A	NONSYN	259	261	GTA	871	873	GCA	149;146;147	G;C;A	149;146;147	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	V130L	NONSYN	388	390	GTC	1000	1002	CTC	196;198;197	C;T;C	196;198;197	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	R135C	NONSYN	403	405	CGC	1015	1017	TGT	198;196;198	T,C;G;T	197,1;196;198	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	T137A	NONSYN	409	411	ACG	1021	1023	GCG	197;197;200	G;C;G,A	197;197;199,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1063	1065	AAG	200;201;199	A;A;G	200;201;199	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1066	1068	AAT	199;200;200	A;A,C;T	199;199,1;200	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1264	1266	TTG	131;129;127	T,C;T;G	130,1;129;127	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1294	1296	AGC	117;117;115	A,G;G;C	116,1;117;115	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1363	1365	CTG	108;107;105	C;T,G;G	108;105,2;105	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1369	1371	TCC	102;101;102	T,G;C;C,T	101,1;101;101,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1384	1386	GTG	113;112;115	G;T;G,C	113;112;113,2	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1550	folP	852	852	93.78	folP.l15.c30.ctg.1	2139	90.5	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1435	1437	GCG	159;160;160	G;C;G	159;160;160	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4920	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3907	157.0	1	SNP	p	S91F	0	.	.	271	273	TCC	878	880	TCC	177;179;179	T,G;C;C,G	176,1;179;178,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4920	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3907	157.0	1	SNP	p	D95G	0	.	.	283	285	GAC	890	892	GAC	184;185;184	G;A;C,T	184;185;183,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4920	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3907	157.0	1	SNP	p	D95N	0	.	.	283	285	GAC	890	892	GAC	184;185;184	G;A;C,T	184;185;183,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	531	1774	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1785	123.7	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	952	952	T	193	T	193	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1066	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1464	90.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4410	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3500	157.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1782	1784	ATC	203;203;200	A;T,C;C	203;202,1;200	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4410	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3500	157.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1935	1937	GCA	223;224;225	G;C,G,A;A	223;222,1,1;225	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4410	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3500	157.2	1	SNP	p	D86N	0	.	.	256	258	GAC	888	890	GAC	181;182;179	G;A,C;C,G	181;180,2;178,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4410	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3500	157.2	1	SNP	p	S87I	0	.	.	259	261	AGT	891	893	AGT	179;180;181	A,C;G;T	178,1;180;181	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4410	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3500	157.2	1	SNP	p	S87R	0	.	.	259	261	AGT	891	893	AGT	179;180;181	A,C;G;T	178,1;180;181	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4410	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3500	157.2	1	SNP	p	S87W	0	.	.	259	261	AGT	891	893	AGT	179;180;181	A,C;G;T	178,1;180;181	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4410	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3500	157.2	1	SNP	p	S88P	0	.	.	262	264	TCC	894	896	TCC	181;181;184	T,G;C,A;C	180,1;180,1;184	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4164	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3217	161.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1863	1865	GGC	226;224;223	G,C;G;C,A	225,1;224;222,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1480	1482	GCA	240;241;244	G;C;A,C	240;241;243,1	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1483	1485	ATC	246;246;251	A,G;T;C	245,1;246;251	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1495	1497	GTG	256;255;254	G;T,C;G,T	256;254,1;253,1	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1495	1497	GTG	256;255;254	G;T,C;G,T	256;254,1;253,1	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1999	2001	ACC	228;229;228	A;C;C	228;229;228	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2053	2055	GCG	227;225;224	G;C,A;G	227;224,1;224	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2053	2055	GCG	227;225;224	G;C,A;G	227;224,1;224	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2176	2178	GGT	229;228;229	G,T;G,T;T,G	228,1;227,1;228,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2185	2187	GGC	240;240;241	G,T,C;G;C	237,2,1;240;241	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4004	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2819	177.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2203	2205	CCG	235;232;228	C,T;CG,C;G	233,2;220,1;228	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5354	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3490	191.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2248	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2342	119.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	847	847	C	186	C,A	185,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	22;23;24	T;T;A	22;23;24	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	52;52;52	C;A;T	52;52;52	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	52;52;52	A;G;T	52;52;52	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	52;52;52	T;A;C	52;52;52	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	1;1;1	G;A;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	1;1;1	A;T;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	268	porB1a	984	226	90.71	porB1a.l15.c17.ctg.1	311	26.8	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	1;2;3	G;T;T	1;2;3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1639	211.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1089	1089	T	230	T,G	229,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1639	211.5	1	SNP	p	G120K	0	.	.	358	360	GGT	816	818	GGT	221;223;223	G;G;T	221;223;223	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1639	211.5	1	SNP	p	A121N	0	.	.	361	363	GCC	819	821	GCC	223;223;222	G;C;C	223;223;222	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2894	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1639	211.5	1	SNP	p	A121D	0	.	.	361	363	GCC	819	821	GCC	223;223;222	G;C;C	223;223;222	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9230	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5310	216.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2310	2312	CAT	229;230;232	C;A,C;T	229;229,1;232	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1446	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1456	123.3	1	SNP	p	V57M	1	.	.	169	171	ATG	794	796	ATG	241;240;239	A;T;G	241;240;239	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
